+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Premature Ejaculation Disorder Therapeutics Market in US 2021-2025- Product Image

Premature Ejaculation Disorder Therapeutics Market in US 2021-2025

  • ID: 5309578
  • Report
  • March 2021
  • Region: United States
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • Bayer AG
  • Eli Lilly and Co.
  • Pfizer Inc.
  • Sandoz AG
  • Solco Healthcare
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Premature ejaculation disorder therapeutics market in US 2021-2025

The publisher has been monitoring the premature ejaculation disorder therapeutics market in US and it is poised to grow by $ 348.66 mn during 2021-2025 progressing at a CAGR of 10% during the forecast period. The report on premature ejaculation disorder therapeutics market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current us market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high efficacy of off-label drugs leading to high usage by end-users, demand for topical drug therapies for premature ejaculation treatment, and growing risk factors causing premature ejaculation. In addition, High efficacy of off-label drugs leading to high usage by end-users is anticipated to boost the growth of the market as well.

The premature ejaculation disorder therapeutics market in US market analysis includes type segment and geographical landscapes.

The premature ejaculation disorder therapeutics market in US is segmented as below:

By Type
  • Oral
  • Topical
By Product
  • SSRIs
  • PDE5 inhibitors
  • Amide anesthetics
  • Others
This study identifies the advent of nanotechnology as one of the prime reasons driving the premature ejaculation disorder therapeutics market in US growth during the next few years. Also, increasing research and development and emergence of novel wearable products will lead to sizable demand in the market.

The report on premature ejaculation disorder therapeutics market in US covers the following areas:
  • Premature ejaculation disorder therapeutics market in US sizing
  • Premature ejaculation disorder therapeutics market in US forecast
  • Premature ejaculation disorder therapeutics market in US industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading premature ejaculation disorder therapeutics market in US vendors that include Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Bayer AG, Eli Lilly and Co., InvaGen Pharmaceuticals Inc., Pfizer Inc., Sandoz AG, Solco Healthcare, and Teva Pharmaceutical Industries Ltd.. Also, the premature ejaculation disorder therapeutics market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Eli Lilly and Co.
  • Pfizer Inc.
  • Sandoz AG
  • Solco Healthcare
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Route of Administration
  • Market segments
  • Comparison by Route of Administration
  • Oral - Market size and forecast 2020-2025
  • Topical - Market size and forecast 2020-2025
  • Market opportunity by Route of Administration
Market Segmentation by Drug Class
  • Market segments
  • Comparison by Drug Class
  • SSRIs - Market size and forecast 2020-2025
  • PDE5 inhibitors - Market size and forecast 2020-2025
  • Amide anesthetics - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by Drug Class
Customer Landscape
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Absorption Pharmaceuticals LLC
  • Alembic Pharmaceuticals Inc.
  • Amneal Pharmaceuticals Inc.
  • Bayer AG
  • Eli Lilly and Co.
  • InvaGen Pharmaceuticals Inc.
  • Pfizer Inc.
  • Sandoz AG
  • Solco Healthcare
  • Teva Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Other1 - Market share 2020-2025 (%)
  • Comparison by Other1
  • Oral - Market size and forecast 2020-2025 ($ million)
  • Oral - Year-over-year growth 2020-2025 (%)
  • Topical - Market size and forecast 2020-2025 ($ million)
  • Topical - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Other1
  • Other2 - Market share 2020-2025 (%)
  • Comparison by Other2
  • SSRIs - Market size and forecast 2020-2025 ($ million)
  • SSRIs - Year-over-year growth 2020-2025 (%)
  • PDE5 inhibitors - Market size and forecast 2020-2025 ($ million)
  • PDE5 inhibitors - Year-over-year growth 2020-2025 (%)
  • Amide anesthetics - Market size and forecast 2020-2025 ($ million)
  • Amide anesthetics - Year-over-year growth 2020-2025 (%)
  • Others - Market size and forecast 2020-2025 ($ million)
  • Others - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Other2
  • Customer landscape
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Absorption Pharmaceuticals LLC - Overview
  • Absorption Pharmaceuticals LLC - Product and service
  • Absorption Pharmaceuticals LLC - Key offerings
  • Absorption Pharmaceuticals LLC - Key customers
  • Absorption Pharmaceuticals LLC - Segment focus
  • Alembic Pharmaceuticals Inc. - Overview
  • Alembic Pharmaceuticals Inc. - Product and service
  • Alembic Pharmaceuticals Inc. - Key offerings
  • Alembic Pharmaceuticals Inc. - Key customers
  • Alembic Pharmaceuticals Inc. - Segment focus
  • Amneal Pharmaceuticals Inc. - Overview
  • Amneal Pharmaceuticals Inc. - Business segments
  • Amneal Pharmaceuticals Inc. - Key offerings
  • Amneal Pharmaceuticals Inc. - Key customers
  • Amneal Pharmaceuticals Inc. - Segment focus
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key offerings
  • Bayer AG - Key customers
  • Bayer AG - Segment focus
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Business segments
  • Eli Lilly and Co. - Key offerings
  • Eli Lilly and Co. - Key customers
  • Eli Lilly and Co. - Segment focus
  • InvaGen Pharmaceuticals Inc. - Overview
  • InvaGen Pharmaceuticals Inc. - Product and service
  • InvaGen Pharmaceuticals Inc. - Key offerings
  • InvaGen Pharmaceuticals Inc. - Key customers
  • InvaGen Pharmaceuticals Inc. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Sandoz AG - Overview
  • Sandoz AG - Product and service
  • Sandoz AG - Key offerings
  • Sandoz AG - Key customers
  • Sandoz AG - Segment focus
  • Solco Healthcare - Overview
  • Solco Healthcare - Product and service
  • Solco Healthcare - Key offerings
  • Solco Healthcare - Key customers
  • Solco Healthcare - Segment focus
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Key customers
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Eli Lilly and Co.
  • Pfizer Inc.
  • Sandoz AG
  • Solco Healthcare
The publisher recognizes the following companies as the key players in the premature ejaculation disorder therapeutics market in US: Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Bayer AG, Eli Lilly and Co., InvaGen Pharmaceuticals Inc., Pfizer Inc., Sandoz AG, Solco Healthcare, and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advent of nanotechnology .'

According to the report, one of the major drivers for this market is the high efficacy of off-label drugs leading to high usage by end-users.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Absorption Pharmaceuticals LLC
  • Alembic Pharmaceuticals Inc.
  • Amneal Pharmaceuticals Inc.
  • Bayer AG
  • Eli Lilly and Co.
  • InvaGen Pharmaceuticals Inc.
  • Pfizer Inc.
  • Sandoz AG
  • Solco Healthcare
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll